Bayer Files Marketing Authorization Applications for New Indication of Finerenone in US, China

USA
EnglishUK
EnglishIndia
EnglishAustralia
EnglishCanada
EnglishFrance
FrançaisSuisse
FrançaisEspaña
EspañolDeutschland
DeutschÖsterreich
DeutschSchweiz
DeutschBelgië
NederlandsNederland
NederlandsItalia
ItalianoSverige
Svenska
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.38 EUR | -1.13% |
|
+2.05% | +10.67% |
02-14 | Germany's DAX Index Falls Amid Fresh US Tariff Anxiety | MT |
02-14 | Bayer Seeks Market Authorization in Japan for Heart Failure Treatment | MT |